furious seasons has a rather distressing piece of news from a recent bristol myers squibb conference call to sum it up quickly , bms claims that of depressed patients are now receiving atypical antipsychotics of those , are taking abilify so that would mean roughly in depressed patients are taking antipsychotics and of them are on abilify i shudder to think how many are on seroquel or zyprexa it made me think of a post i wrote a few weeks ago in which i described the marketing of abilify for depression a huge market of depressed people just ripe for the picking going along with this , bms is pushing back on the issue of akathisa , the side effect that has garnered the drug much bad publicity at least in the blog world , , via a medical journal article that distracts attention from abilify as an akathisia inducer more on that to come soon ghostwriters , ignoring contradictory evidence basically , an attempt to completely obscure the evidence on the topic it 's not the first time bms has successfully placed a study with major flaws into a medical journal , details will be forthcoming